Xanttos Biomedicine GmbH Company Profile

23:55 EDT 19th September 2017 | BioPortfolio

Xantos Biomedicine – the new dimension in genomics drug discovery

Xantos is a biotechnology company applying a unique and novel technology (XantoScreen™) for the rapid identification of previously unknown, medically relevant genes in human cDNA-libraries. This is the basis to discover therapeutical targets for LMW drugs, genes, proteins and antibodies for direct therapeutic use, as well as diagnostic targets.

Xantos represents the next generation in genomics drug discovery. Xantos offers product development partnerships for pharmaceutical and life-science companies. Xantos will also apply its discoveries towards developing an internal portfolio of patented drug candidates.


Fraunhoferstr. 22


Phone: 49 89 899 59 400
Fax: 49 89 899 59 420

News Articles [253 Associated News Articles listed on BioPortfolio]

Cellular Biomedicine Group (CBMG) - A transpacific cell therapy company

Edison Investment Research - Pharmaceutical & healthcare - Cellular Biomedicine Group: Cellular Biomedicine Group (CBMG) has seven preclinical CAR-T programs and two Phase I clinical trials using its ...

FDA grants orphan status to H3 Biomedicine's leukemia drug candidate

H3 Biomedicine's orally administered lead candidate, H3B-8800, was granted orphan drug designation by the FDA as a treatment  -More- 

FDA grants orphan drug status to H3 Biomedicine’s cancer treatment H3B-8800

H3 Biomedicine, a member of Eisai’s global Oncology Business Group, has received orphan drug designation from the US Food and Drug Administration (FDA) for its H3B-8800, a clinical compound used to ...

H3 Biomedicine initiates dosing in Phase I trial of breast cancer drug

H3 Biomedicine, a member of Eisai’s Oncology business group, has started dosing patients in a Phase I clinical trial of H3B-6545 as a monotherapy to treat breast cancer.

Study on Covalent Antagonist of Estrogen Receptor Gets Underway

NewsH3 Biomedicine announces first patient dosed with H3B-6545 in phase 1 study in breast cancer. Preclinical data indicates H3B-6545 inhibits the growth of cell line and patient-derived xenograft mod...

H3 Biomedicine gets FDAorphan drug status for acute myelogenous leukemia treatment

The US Food and Drug Administration (FDA) has granted orphan drug designation for H3 Biomedicine's H3B-8800, its lead clinical compound for the treatment of patients with Acute Myelogenous Leukemia (A...

Identified the component that allows a lethal bacteria to spread resistance to antibiotics

(Institute for Research in Biomedicine (IRB Barcelona)) A study performed at the Institute for Research in Biomedicine (IRB Barcelona) and involving the collaboration of the Centro de Investigaciones ...

Orphan Drug Designation Granted for Acute and Chrinic Leukemia Treatments

NewsH3 Biomedicine granted orphan drug designation of H3B-8800 for treatment of acute myelogenous leukemia and chronic myelomonocytic leukemia.

PubMed Articles [199 Associated PubMed Articles listed on BioPortfolio]

Corrigendum to 'Pregnancy derived from human zygote pronuclear transfer in a patient who had arrested embryos after IVF' Reproductive BioMedicine Online 33 (2016) 529-533.

Corrigendum to "DISTING: A web application for fast algorithmic computation of alternative indistinguishable linear compartmental models" Computer Methods and Programs in Biomedicine 143 (2017) 129-135.

Photonic crystal materials and their application in biomedicine.

Photonic crystal (PC) materials exhibit unique structural colors that originate from their intrinsic photonic band gap. Because of their highly ordered structure and distinct optical characteristics, ...

Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity: The TOWER study.

To evaluate safety (primary objective) and efficacy of increasing doses (400 U up to 800 U) of incobotulinumtoxinA (Xeomin, Merz Pharmaceuticals GmbH) for patients with limb spasticity.

Biomechanical Characterization of Subclinical Keratoconus Without Topographic or Tomographic Abnormalities.

To present a case series of patients with subclinical keratoconus with normal topometric (anterior curvature) and tomographic findings in one eye who showed abnormalities detected by Corvis ST (Oculus...

Clinical Trials [41 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

Frozen Embryo Transfer in Natural and Hormonal Replacement Cycles

This study is a prospective randomized controlled trial to compare the pregnancy outcomes of frozen embryo transfer in natural and hormonal replacement cycles. The study population consist...

Study and Development of Application Models of "Therapeutic Education to the Patient" (TEP) in Asthmatic Children

It is an interventional prospective study. The study will assess the intervention of the "Therapeutic Education to the Patient (TEP)" on the quality of life in asthmatic children. The pat...

User Performance Evaluation of Contour® Plus One, Accu-Chek® Performa Connect, FreeStyle Optium Neo and OneTouch® Select Plus Blood Glucose Monitoring Systems Following ISO 15197:2013; EN ISO 15197:2015

The user performance evaluation shows whether people with diabetes are able to obtain accurate measurement results with a blood glucose monitoring system. In this study, user performance e...

Companies [543 Associated Companies listed on BioPortfolio]

Xanttos Biomedicine GmbH

Xantos Biomedicine – the new dimension in genomics drug discoveryXantos is a biotechnology company applying a unique and novel technology (XantoScreen™) for the rapid identification of previously ...

H3 Biomedicine Inc.

H3 Biomedicine is a biopharmaceutical company specializing in the discovery and development of oncology treatments. Using modern synthetic chemistry, chemical biology and human ge...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

OctreoPharm Sciences GmbH

OctreoPharm Sciences GmbH, located in Berlin (Germany) is a privately held clinical development company focusing on radiopharmaceuticals for the diagnosis and therapeutic control ...

LionexDiagnostics & Therapeutics GmbH

Lionex is a biotech company dedicated to modern biomedicine for human health. Considering the revolutionary pace at which human and microbial genomic sequence information is progressing, it is becomin...

More Information about "Xanttos Biomedicine GmbH" on BioPortfolio

We have published hundreds of Xanttos Biomedicine GmbH news stories on BioPortfolio along with dozens of Xanttos Biomedicine GmbH Clinical Trials and PubMed Articles about Xanttos Biomedicine GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Xanttos Biomedicine GmbH Companies in our database. You can also find out about relevant Xanttos Biomedicine GmbH Drugs and Medications on this site too.

Quick Search

Relevant Topics

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Corporate Database Quicklinks

Searches Linking to this Company Record